Drexel Morgan & Co. lifted its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 32,924 shares of the healthcare product maker’s stock after purchasing an additional 475 shares during the period. Abbott Laboratories makes up approximately 0.7% of Drexel Morgan […]